This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Personal Story: Hannah Eckstein

Hannah Eckstein was diagnosed with glaucoma just a few months after she was born. Now she is 17 and starting college.

A Father’s Gift Honors His Son’s Achievements

“I’ve been inspired by Paul’s remarkable courage and perseverance to not let his glaucoma keep him from leading a full life,” says his father.

Combination Surgery: Treating Cataracts and Glaucoma Together

Cataracts are like wrinkles — everyone gets them when they get older. When people with glaucoma get cataracts, it’s the perfect opportunity to treat both problems at once.

Personal Story: Igor Leal

Igor Leal is a talented singer-songwriter living with glaucoma.

Q&A: New Medications for Glaucoma

In this “Questions and Answers” article, learn about new glaucoma medications available in 2019, how they’re different from existing treatments, and their potential side effects.

The Path To A Cure for Glaucoma

Every day, glaucoma researchers work to better understand and find safer, more effective ways to treat this debilitating disease.

Stem Cell Therapy for Glaucoma – Are We There Yet?

Stem cell therapies are getting headlines for their potential to cure diseases, including those that affect vision. But an important message is missing: stem cell therapies are not yet proven to be safe and effective for your eyes.

UK Research Study Reports Laser-based Glaucoma Treatment is More Successful and Cost-effective

The published UK study suggests Selective Laser Trabeculoplasty should become the principal method for treating patients with glaucoma.

FDA Approves Rocklatan Eye Drop for Open-Angle Glaucoma

The FDA has approved Rocklatan, a once-daily IOP-lowering eye drop for patients with open-angle glaucoma, Aerie Pharmaceuticals announced in a press release this week.

Dr. Adriana Di Polo Awarded the 2019 Shaffer Prize from Glaucoma Research Foundation

Dr. Di Polo’s laboratory investigated the hypothesis that insulin can improve the survival and function of injured retinal ganglion cells and may be viable as an innovative glaucoma treatment.

Catalyst for a Cure: A Clear Path to Vision Restoration

For the first time, thanks to improvements in how we measure the disease, researchers are studying and testing new therapeutic candidates for neuroprotection, neuroenhancement, and visual restoration.

2018 Weston Lecture by Jeffrey Goldberg, MD, PhD

Listen to the 2018 Weston Glaucoma Research Lecture delivered by Jeffrey Goldberg, MD, PhD, a principal investigator in the Catalyst for a Cure.

Rare Forms of Glaucoma

Although primary open-angle glaucoma is the most common type of glaucoma, there are many other types of eye disorders that fall under the spectrum of glaucoma.

Glaucoma and Reading Ability

What can be done to make reading easier for those with glaucoma? You can start by trying some things on your own.

New Priorities for Glaucoma Research

New approaches to treating, managing, and even curing glaucoma are essential to patients and caregivers. Researchers are actively working to advance the field in several key areas.

Impact of GRF Shaffer Grants: Funding Important Research Discoveries

Research outcomes from past Shaffer Grant recipients demonstrate the impact of this funding in catalyzing the growth, sustainability, and productivity of glaucoma research laboratories across the US.

Recall: CyPass Micro-Stent Withdrawn Amid Concerns of Endothelial Cell Loss

August 29, 2018 — Alcon has issued a voluntary global recall of the CyPass microstent, effective immediately.

Carla Siegfried, MD: Innovative Glaucoma Research

“I became interested in glaucoma because I liked the long-term aspect of it. It is through that long-term relationship that we can really get to know our patients and help them.” — Carla Siegfried, MD

Glaucoma Research Foundation Grant Leads to Major Breakthrough in Neuron Regeneration

Study indicates treatment using insulin may restore vision in glaucoma patients.

Impact of GRF Shaffer Grants: Catalyzing the Careers of Glaucoma Researchers

Glaucoma Research Foundation Shaffer Grants present a unique opportunity for investigators to pursue innovative ideas in the spirit of high risk/high reward scientific discovery.

President’s Report from ARVO 2018

ARVO is the annual meeting of the Association for Research in Vision and Ophthalmology.

Niki’s Story: Putting a Positive Spin on her Glaucoma

“Whatever curves life throws at us, I believe one must always make the best out of a situation; there is always a positive side.” – Niki De Lara

New Drug Rhopressa Now Available for Open-Angle Glaucoma

Rhopressa 0.02% is a novel once-daily eye drop for lowering elevated intraocular pressure.

Generic Medications: Are They the Same?

Generic drugs work well for most patients, but there are differences compared to the brand name products.

Glaucoma and Driving Ability

Concerns about driving often come up with glaucoma and may be brought to the doctor’s attention by the patient or a family member.